163 related articles for article (PubMed ID: 35295035)
1. Ethambutol-induced bullous skin lesions in
Kollipara VK; Horowitz M; Lantz J; Nagy-Agren S
Int J Mycobacteriol; 2022; 11(1):120-122. PubMed ID: 35295035
[TBL] [Abstract][Full Text] [Related]
2. [Distribution and drug resistance of nontuberculous
Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817
[No Abstract] [Full Text] [Related]
3. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
[No Abstract] [Full Text] [Related]
5. [Nontuberculous mycobacterial infections of the lung].
Latshang TD; Lo Cascio CM; Russi EW
Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
[TBL] [Abstract][Full Text] [Related]
6. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
[TBL] [Abstract][Full Text] [Related]
7. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Zhang M; Feng M; He JQ
Int J Infect Dis; 2017 Sep; 62():59-63. PubMed ID: 28712930
[TBL] [Abstract][Full Text] [Related]
8. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
[TBL] [Abstract][Full Text] [Related]
9. Disseminated coinfection with Mycobacterium Avium complex and Mycobacterium Kansasii in a patient with idiopathic CD4
Somboonviboon D; Thongtaeparak W; Suntavaruk P; Nasomsong W
J Infect Chemother; 2023 Dec; 29(12):1167-1171. PubMed ID: 37562711
[TBL] [Abstract][Full Text] [Related]
10. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline].
Wagner D; Lange C
Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550
[TBL] [Abstract][Full Text] [Related]
11. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
Tsang AY; Bentz RR; Schork MA; Sodeman TM
Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
14. Rapid improvement of Mycobacterium kansasii pneumonia after rifabutin, isoniazid, and ethambutol: A case report.
Kuo HI; Huang ST; Wu YH
Kaohsiung J Med Sci; 2022 Nov; 38(11):1137-1138. PubMed ID: 36254860
[No Abstract] [Full Text] [Related]
15. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
da Silva Telles MA; Chimara E; Ferrazoli L; Riley LW
J Med Microbiol; 2005 Oct; 54(Pt 10):975-979. PubMed ID: 16157553
[TBL] [Abstract][Full Text] [Related]
16. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
[TBL] [Abstract][Full Text] [Related]
17. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Ibarrola M; Baraia-Etxaburu J; Sánchez R; Teira R; Unzaga J; Miguel Santamaría J
Enferm Infecc Microbiol Clin; 2001 Feb; 19(2):80-2. PubMed ID: 11333577
[No Abstract] [Full Text] [Related]
18. Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea.
Park HK; Koh WJ; Shim TS; Kwon OJ
Yonsei Med J; 2010 Jul; 51(4):552-6. PubMed ID: 20499421
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
20. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis.
Forslöw U; Geborek A; Hjelte L; Petrini B; Heurlin N
Acta Paediatr; 2003 Aug; 92(8):910-5. PubMed ID: 12948065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]